This study now shows that one of them, i.e. climacostol, is also a powerful and efficacious anti-cancer agent targeting the intrinsic apoptotic programme linked to p53 system, which may be used in vivo, for instance, in intra-lesion therapy approaches. The gene discussed is TP53; the disease is cancer.